Literature DB >> 18475478

Suppressive effect of TNF-alpha and IL-1 on alveolar fibroblast proliferation in sarcoidosis.

E Fireman1, D Aderka, S B Efraim, J Greif, D Wallach, M Topilsky.   

Abstract

The nature of soluble factors that regulate fibroblast proliferation have not been finally characterized. Our aim was to study the role of tumour necrosis factor alpha (TNF-alpha) and interleukin-1 (IL-1) in the suppressive activity of alveolar macrophages on autologous lung fibroblasts proliferation in sarcoidosis. We found that supernatants recovered from alveolar macrophages suppressed the proliferation of alveolar fibroblast in sarcoidosis by 35.5 +/- 1.13% compared to 3 +/- 16% in controls (p < 0.001 between the two groups). This suppression correlated with high content of TNF-alpha and IL-1 in sarcoidosis patients stage II-III (7.7 +/- 2.9 ng/ml TNF-alpha and 157 +/- 53 U/ml IL-1 compared to 3.4 +/- 2.4 ng/ml TNF-alpha and 43 U/ml IL-1 in controls; p < 0.01 and p < 0.001, respectively). Both cytokines in sarcoidosis stage I were within the normal ranges. Exogenous TNF-alpha (1000-0.5 ng/ml) and IL-1 (500-0.24 ng/ml) had an additive suppressive activity on fibroblast proliferation which was partially reversed by indomethacin.

Entities:  

Year:  1992        PMID: 18475478      PMCID: PMC2365356          DOI: 10.1155/S0962935192000474

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  14 in total

1.  Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation.

Authors:  J A Elias; S A Jimenez; B Freundlich
Journal:  Am Rev Respir Dis       Date:  1987-01

2.  Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms.

Authors:  J A Elias
Journal:  Am Rev Respir Dis       Date:  1988-09

3.  Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity.

Authors:  M Gowen; D D Wood; R G Russell
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

4.  Cell-free supernatants of sarcoid alveolar macrophages suppress proliferation of sarcoid alveolar fibroblasts.

Authors:  E Fireman; S Ben Efraim; G Messer; S Dabush; J Greif; M Topilsky
Journal:  Clin Immunol Immunopathol       Date:  1991-06

5.  Human alveolar macrophage and blood monocyte inhibition of fibroblast proliferation. Evidence for synergy between interleukin-1 and tumor necrosis factor.

Authors:  J A Elias; K Gustilo; B Freundlich
Journal:  Am Rev Respir Dis       Date:  1988-12

6.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

7.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04

8.  Blood and lung mononuclear cell inhibition of fibroblast growth in sarcoidosis.

Authors:  J A Elias; M D Rossman; R P Daniele
Journal:  Am Rev Respir Dis       Date:  1984-12

9.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

10.  Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process.

Authors:  J A Elias; M D Rossman; R B Zurier; R P Daniele
Journal:  Am Rev Respir Dis       Date:  1985-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.